Core One Labs Inc. (CLABF)

0.1576 0.0000 (0.00%) As of 11:21AM EDT. Market open.

Core One Labs Inc.

1199 West Hastings Street
Suite 800
Vancouver, BC V6E 3T5
Canada
888-452-6731
https://core1labs.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Joel Shacker	CEO & Director	176.67k	N/A	1991
Mr. Geoffrey Balderson	CFO, Secretary & Director	29.78k	N/A	1978
Dr. Santiago Ferro	Chief Medical Officer & Director	72.78k	N/A	N/A
Mr. Brad Paul Eckenweiler	Founder & Advisor	N/A	N/A	1954
Mr. Jan Burian Ph.D.	Chief Technical Officer	N/A	N/A	N/A
Dr. Elizabeth Matthews	Head of Scientific & Regulatory Affairs	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.

Corporate Governance

Core One Labs Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.